Journal of Surgical Oncology · 2007 · 71 citations · 46 references
MedicineOncologyPathologyCell AdhesionGastrointestinal OncologyTumor ProgressionAdhesion MoleculesCancer BiomarkersCancer ProgressionCell-matrix AdhesionColorectal CancerMalignant NeoplasmsAdhesion Molecule BiomarkersCd44 ExpressionColorectal Cancer PrognosisE-cadherin LossImmunohistochemical BiomarkersImmunohistochemical MarkersImmunohistochemical StainingTumor Differentiation Assessment
BACKGROUND AND OBJECTIVES: Adhesion molecules are implicated in the progression of colorectal cancer (CRC). Despite the evidence of association between their expression and patients' prognosis, the data have not been examined simultaneously in a same study; thus, the relative clinical value remained largely unknown. The aim of this study was to identify the adhesion factors that display the most significant prognostic value for CRC patients to guide clinical decision-making regarding appropriate treatment. PATIENTS AND METHODS: We examined by immunohistochemistry, the expression of E-cadherin and its associated catenins, alpha(alpha)-catenin and beta(beta)-catenin, DCC, and CD44 and its partner, MT1-MMP in a series of 140 CRC tissues at intermediate Stage II and Stage III to determine their prognostic significance. RESULTS: Clinicopathological survey indicated an inverse relationship between E-cadherin expression and tumor differentiation, and an association between CD44 expression and venous invasion. Univariate and multivariate analyses showed that loss of expression of E-cadherin and CD44 significantly correlated to poor survival, especially in Stage II. Combination studies indicated that loss of E-cadherin and loss of CD44 had the worst impact on patient prognosis, particularly in colon cancer. CONCLUSION: Immunohistochemical staining of E-cadherin and CD44 may help to identify a subgroup of high-risk patients with Stage II CRC, especially in colon cancer, who may need intensive follow-up and appropriate therapeutic strategy.
46
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Rolf Sauer, Heinz Becker, Werner Hohenberger et al. · New England Journal of Medicine · 2004 · 6.1K citations
Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
Eric R. Fearon, Kathleen R. Cho, Janice Nigro et al. · Science · 1990 · 1.7K citations
Life Sciences, Genetics, Oncology +17
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.
U. Frixen, Jürgen Behrens, Matthew S. Sachs et al. · The Journal of Cell Biology · 1991 · 1.6K citations · Full text
Medicine, Cell Biology, Oncology +17
Guidelines 2000 for Colon and Rectal Cancer Surgery
H. Nelson, Nicholas J. Petrelli, Arthur M. Carlin et al. · JNCI Journal of the National Cancer Institute · 2001 · 1.3K citations · Full text